ViCentra Collaborates with Diabeloop and Dexcom to Launch Closed-Loop Diabetes System in Europe

ViCentra, in collaboration with Diabeloop and Dexcom, is set to introduce a new hybrid closed-loop system for managing Type 1 diabetes in Europe. The system utilizes advanced technology to seamlessly integrate ViCentra’s insulin pump, Diabeloop’s algorithm, and Dexcom’s G6 sensor, offering an effective solution for personalized diabetes management.

The hybrid closed-loop system operates through Diabeloop’s algorithm, which analyzes real-time blood sugar readings from the Dexcom G6 continuous glucose monitor. The algorithm then adjusts the output of ViCentra’s insulin pump throughout the day, providing users with optimal insulin doses.

The European launch of the artificial pancreas system is scheduled to commence this year in France, the Netherlands, and Germany, with further expansion across the continent, including the U.K. and Italy, in 2024. ViCentra and Diabeloop will jointly oversee the rollout, leveraging their established European distribution partnership formed in 2019.

Several years of collaborative research by ViCentra, Diabeloop, and Dexcom have contributed to the development of this innovative diabetes management system. A notable study published in Diabetes Care in 2021 demonstrated positive outcomes, with participants experiencing a significant drop in average HbA1c levels and improved time spent in a healthy glucose range.

All three components of the system—ViCentra’s Kaleido insulin pumps, Diabeloop’s algorithm, and Dexcom’s G6 sensor—have obtained CE mark clearance in Europe since 2018. ViCentra’s Kaleido insulin pumps offer users customization options, including 10 color choices and the flexibility to be worn as a patch pump or carried in a pocket with longer tubing. The system also features two rechargeable pumps, ensuring continuous availability, and a user-friendly interface for self-monitoring and dosage adjustments.

The closed-loop system not only empowers users to manage their insulin dosages but also allows Diabeloop’s algorithm to make automated, round-the-clock adjustments based on real-time data from the Dexcom G6 sensor, as well as individual biological information, recent meals, and exercise. The system’s design aims to enhance user experience, reduce waste, and contribute to more effective and personalized diabetes care.